Finasteride

What is Dragon Pharma Finasteride?
Finasteride is a synthetic 4-azasteroid compound primarily used to manage androgenic conditions such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness). It works by selectively inhibiting the enzyme 5-alpha-reductase, preventing the conversion of testosterone to dihydrotestosterone (DHT). In research, Finasteride is studied for its effects on hormone regulation, prostate health, hair follicle dynamics, and androgen-mediated signaling pathways, making it a key tool in endocrinology and dermatology studies.

Mechanism of Action:
Finasteride functions as a competitive inhibitor of 5-alpha-reductase types I and II, enzymes responsible for converting testosterone into DHT, a potent androgen that contributes to prostate enlargement and hair follicle miniaturization. By lowering DHT levels, Finasteride reduces androgenic stimulation of target tissues, which supports research in hair growth, prostate volume regulation, and hormonal modulation. Its mechanism provides insight into androgen-dependent processes and therapeutic strategies in male reproductive and dermatological studies.

Benefits:

• Reduces dihydrotestosterone (DHT) levels in the scalp and prostate.
• Slows or prevents progression of androgenetic alopecia.
• Supports reduction of prostate volume and associated urinary symptoms.
• Provides a research model for studying androgen-dependent tissue changes.

Research Applications:

• Investigating mechanisms of androgenetic alopecia and hair follicle biology.
• Studying benign prostatic hyperplasia and prostate tissue modulation.
• Evaluating the effects of DHT suppression on hormonal balance and metabolism.
• Exploring androgen-related pathways in endocrine and dermatological research.

Dosing Instructions:

• Dosing: Oral tablets; dosage should be consistent and in accordance with research protocols.
• Daily Dose: Typically 1 mg daily for hair loss research or 5 mg daily for BPH-related studies.
• Route: Oral.
• Duration: Research cycles often range from 3–12 months to assess hair growth or prostate response.
• Frequency: Once daily.
• Recommended Cycles: Continuous administration is generally required for sustained effects; follow research protocol or study design.
• PCT: Not required, but monitoring of hormone levels may be necessary in experimental studies.

Stacking With Other Products:

• Minoxidil for synergistic hair regrowth effects in androgenetic alopecia studies.
• Biotin and other hair-nourishing supplements to support follicle health.
• Saw Palmetto extract in experimental protocols evaluating DHT suppression.
• Ketoconazole shampoo in dermatological research for enhanced scalp DHT control.

Side Effects:

• Decreased libido or sexual dysfunction in rare cases.
• Mild gynecomastia or breast tenderness.
• Transient dizziness or headache.
• Rare changes in mood or depressive symptoms in sensitive subjects.

Contraindications:

• Hypersensitivity to Finasteride or excipients in the formulation.
• Women who are or may become pregnant due to risk of fetal abnormalities.
• Children or prepubertal males, as hormonal effects may disrupt development.
• Individuals with severe liver impairment should avoid use without monitoring.

Conclusion
Finasteride is a selective 5-alpha-reductase inhibitor with proven efficacy in reducing DHT levels, managing androgenic hair loss, and supporting prostate health. Its mechanism of action provides a valuable model for endocrine and dermatological research, particularly in androgen-dependent processes. Combining Finasteride with complementary therapies such as minoxidil or saw palmetto may enhance hair regrowth outcomes. Proper dosing, adherence to contraindications, and long-term monitoring ensure safe and effective use in both research and clinical applications.

References:

• Kaufman KD, et al. "Finasteride in the treatment of male pattern hair loss." Journal of the American Academy of Dermatology. 1998;39:578–589.
• McConnell JD, et al. "The effect of Finasteride on the clinical progression of benign prostatic hyperplasia." New England Journal of Medicine. 1998;338:557–563.
• ClinicalTrials.gov Identifier: NCT00004665 – Finasteride for hair loss and prostate health studies.
• Traish AM, et al. "Mechanisms of action of Finasteride and other 5-alpha-reductase inhibitors." Endocrine Reviews. 2011;32:400–431.

Finasteride FAQ

✔️ What is Finasteride?
Finasteride is a research-grade 5-alpha-reductase inhibitor commonly used to study hormonal pathways, DHT regulation, and androgen metabolism in laboratory models.

✔️ How does Finasteride work?
It inhibits the conversion of testosterone to dihydrotestosterone (DHT), allowing researchers to examine androgen-dependent biological processes and tissue responses.

✔️ What are the recommended storage conditions?
Store tablets in a cool, dry place at 15–30°C (59–86°F), away from light, heat, and moisture, in the original packaging until use to preserve potency and stability.

✔️ Is Finasteride safe for laboratory research?
Yes, when handled according to controlled experimental protocols, it is safe for preclinical studies. It is not intended for human consumption.

✔️ Can Finasteride be combined with other compounds?
Yes, in research settings it can be studied alongside androgen modulators, peptides, or hormonal regulators to explore synergistic effects on endocrine pathways.

✔️ How long is Finasteride stable?
Properly stored tablets remain stable until the expiration date. Avoid crushing, splitting, or exposing them to humidity or extreme temperatures, which can compromise chemical stability and research reliability.

Storage and Safety – Finasteride

Proper storage and handling of Dragon Pharma Finasteride are essential to maintain its potency, chemical stability, and reliability for research and experimental applications. Tablets should be stored in a cool, dry environment at 15–30°C (59–86°F), away from direct sunlight, heat, and moisture, which can degrade the active ingredient and reduce effectiveness. Keep tablets in their original packaging until use to prevent contamination and maintain stability.

Avoid crushing, breaking, or exposing tablets to extreme temperatures, as this may compromise drug integrity and uniformity. Always handle the product with clean, dry hands or sterile tools, and ensure the storage area is free from excess humidity. Keep all tablets out of reach of children, pets, and unauthorized personnel.

Expired or unused tablets should be disposed of according to pharmaceutical waste regulations; do not flush them down drains or discard in household trash. Following proper storage and safety protocols ensures that Finasteride remains fully active, stable, and suitable for controlled research, analytical studies, or experimental use.